Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Screening, surgical cure and new developments: Current state of the art surgery

Share :

Future Horizons in Lung Cancer

1 - 2 Sep 2016
Sorry, this item is currently unavailable.
Published: 5 Oct 2016
Views: 1970
Rating:
Save
Dr Ugo Pastorino - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Dr Pastorino presents at the Future Horizons in Lung Cancer meeting about current state of the art surgery in lung cancer.

 

 

Related Videos

Innovative treatments for solid tumours – TTFields as a therapeutic modality
Dr Giuseppe Lombardi, Dr Helen Bulbeck, Prof Dean Fennell and Dr Tadeja Urbanic...
Innovative treatments for solid tumours – TTFields as a therapeutic modality ( Dr Giuseppe Lombardi, Dr Helen Bulbeck, Prof Dean Fennell and Dr Tadeja Urbanic-Purkart )
2 Nov 2023
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during...
Prof Gerard Zalcman - Université de Paris, Paris, France
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients ( Prof Gerard Zalcman - Université de Paris, Paris, France )
27 Oct 2023
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall...
Dr Neil Gross - MD Anderson Cancer Center, Houston, USA
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC ( Dr Neil Gross - MD Anderson Cancer Center, Houston, USA )
27 Oct 2023
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )
17 Oct 2023
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
Dr Stephen Chun - MD Anderson, Houston, USA
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC ( Dr Stephen Chun - MD Anderson, Houston, USA )
14 Sep 2023
War in Ukraine: The Global Medical Knowledge Alliance's response to improving...
Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care ( Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk )
22 Aug 2023
OncoAlert Round Up for August 4th - 10th, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for August 4th - 10th, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
14 Aug 2023
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity...
Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC ( Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain )
26 Apr 2023
The advantages of IORT for early breast cancer treatment
Dr David Martinez Perez - AUNA, Lima, Peru
The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation